Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Signal Amplificat...

    2026-04-02

    Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Driving Sensitive Mouse IgG Detection in Advanced Immunoassays

    Principle and Setup: Harnessing Cy5-Conjugated Secondary Antibody Power

    The Cy5 Goat Anti-Mouse IgG (H+L) Antibody from APExBIO is a polyclonal secondary antibody engineered for high-sensitivity mouse IgG detection. Conjugated with Cy5—a far-red fluorescent dye—this antibody binds both heavy and light chains of mouse IgG, facilitating robust signal amplification in immunohistochemistry fluorescent detection, immunocytochemistry fluorescence assays, and flow cytometry. Its immuno-affinity purification ensures high specificity and minimal background interference, making it an indispensable tool for fluorescence-based antibody labeling and detection workflows.

    Cy5's emission (max ~670 nm) offers low autofluorescence, enabling superior signal-to-noise ratios, particularly crucial when detecting low-abundance targets or multiplexing. The antibody is supplied at 1 mg/mL in a stabilizing buffer with 23% glycerol, PBS, 1% BSA, and 0.02% sodium azide. This composition not only preserves antibody integrity during storage at -20°C but also ensures consistent performance by minimizing freeze/thaw cycles and protecting the Cy5 dye from photobleaching.

    Step-by-Step Workflow: Protocol Enhancements for Immunodetection

    1. Sample Preparation & Primary Antibody Incubation

    • Immunohistochemistry (IHC)/Immunocytochemistry (ICC): Fix tissue/cell samples with paraformaldehyde (e.g., 4% PFA), permeabilize (e.g., 0.1% Triton X-100 for ICC), and block with 5% BSA or serum to prevent non-specific binding.
    • Flow Cytometry: Harvest and wash cells in PBS containing 1% BSA; block as above.
    • Incubate samples with mouse primary antibody (optimized concentration, typically 1–10 μg/mL) for 1–2 hours at room temperature or overnight at 4°C.

    2. Secondary Antibody Incubation (Cy5 Goat Anti-Mouse IgG (H+L))

    • Prepare the Cy5-conjugated secondary antibody at 1–5 μg/mL in blocking buffer. Protect all solutions and samples from direct light to maintain fluorescence integrity.
    • Incubate samples for 1 hour at room temperature (RT), gently agitating to ensure even distribution.
    • Wash 3–5 times with PBS or appropriate buffer to remove unbound antibody.

    3. Detection and Imaging/Analysis

    • Fluorescence Microscopy: Image samples using Cy5-compatible filter sets (excitation ~650 nm, emission ~670 nm). Expect high sensitivity and low background due to the antibody's specificity and Cy5's spectral properties.
    • Flow Cytometry: Analyze using red/far-red laser excitation; compensation controls are essential for multiplex panels.
    • Quantify fluorescent intensity for comparative or quantitative studies. The signal amplification achieved allows for reliable detection of low-abundance antigens, as demonstrated in antibody titration experiments (signal-to-noise ratio improvements up to 10-fold compared to FITC conjugates[1]).

    This workflow is applicable across a range of immunoassays, from single-target detection to complex multiplexed protocols involving multiple mouse primary antibodies.

    Advanced Applications and Comparative Advantages

    1. Multiplexed Immunofluorescence for Vaccine Research

    In the context of vaccine development, such as the ferritin-based hybrid protein particle vaccine combining M2e antigen of influenza A and S-protein tandem epitopes of SARS-CoV-2 (Song et al., 2026), high-sensitivity fluorescent secondary antibody detection is essential for mapping immune responses. The Cy5 Goat Anti-Mouse IgG (H+L) Antibody enables precise localization of mouse-derived antibodies raised against hybrid antigens in tissue sections and cultured cells. Its far-red emission minimizes spectral overlap, facilitating multi-color immunodetection alongside FITC, Cy3, or Alexa Fluor 488/555-labeled reagents.

    Compared to traditional enzyme-based detection, fluorescence-based immunodetection using Cy5-conjugated secondary antibody offers:

    • Substantially increased dynamic range and quantitative capability
    • Reduced background due to spectral separation from tissue autofluorescence
    • Compatibility with digital image analysis and multiplexed marker studies
    • Rapid workflow—eliminating the need for substrate development

    2. Enhanced Signal Amplification in Low-Abundance Detection

    Because each mouse primary antibody can be bound by multiple Cy5-conjugated secondary antibodies, significant fluorescence signal amplification is achieved. Quantitative studies report at least 5–10-fold enhancement in detection sensitivity compared to directly labeled primary antibodies or lesser-performing fluorophores[2]. This amplification is critical for applications such as detection of weakly expressed antigens or low-titer immune sera, as required in vaccine efficacy or immunogenicity assessments.

    3. Streamlined Flow Cytometry and Immunocytochemistry

    For flow cytometry secondary antibody applications, the Cy5-conjugated antibody enables clear discrimination of positive populations, even in the presence of high background or autofluorescent cells. Its polyclonal nature ensures robust performance across different mouse IgG subclasses, increasing assay reliability. In immunocytochemistry fluorescence labeling, reproducible and intense signals facilitate high-content screening of cellular responses.

    4. Comparative Insights from Published Resources

    Recent articles, such as "Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Advancing Signal...", provide in-depth analysis of signal amplification strategies, complementing the current workflow by addressing quantitative imaging and digital analysis. Meanwhile, the article "Fluorescent Secondary Antibody for Mouse IgG Detection" extends these findings with validation data in multiplex panels, and "Advanced Fluorescent Detection and Signal Amplification" contrasts performance in basic versus translational research contexts. Together, these resources confirm the Cy5 Goat Anti-Mouse IgG (H+L) Antibody's leading role in high-sensitivity, reproducible immunoassays.

    Troubleshooting and Optimization: Maximizing Fluorescent Secondary Antibody Performance

    Common Challenges and Solutions

    • High Background Fluorescence: Ensure thorough blocking (5% BSA/serum), increase wash steps, and optimize antibody dilution. Always protect samples from light to prevent photobleaching, as Cy5 is sensitive to prolonged exposure.
    • Weak or Uneven Signal: Titrate both primary and secondary antibodies—overly high concentrations can cause quenching or non-specific binding, while too little reduces sensitivity. Confirm antibody integrity; avoid repeated freeze/thaw cycles by aliquoting upon first thaw.
    • Non-Specific Staining: Use highly specific, immuno-affinity purified reagents like the APExBIO Cy5 Goat Anti-Mouse IgG (H+L) Antibody. Include isotype controls and optimize blocking for samples with high endogenous IgG.
    • Signal Overlap in Multiplex Panels: Carefully select fluorophores with minimal spectral overlap and use appropriate compensation in flow cytometry. Cy5's far-red emission is ideal for adding extra channels to multiplex assays.
    • Antibody Storage Issues: Store short-term at 4°C for up to 2 weeks or aliquot and keep at -20°C for up to 12 months. Avoid more than 2 freeze/thaw cycles and always protect the antibody from light. The included sodium azide and BSA in the storage buffer help maintain long-term stability and prevent microbial contamination.

    Expert Tips for Enhanced Results

    • For low-expressing targets, extend secondary incubation to 2 hours at RT and increase wash stringency.
    • When using in flow cytometry, validate instrument settings and compensation with single-stain controls for each fluorophore.
    • For quantitative imaging, use standardized exposure times and calibrate fluorescence intensity with reference beads or slides.
    • Batch-to-batch consistency is ensured by APExBIO's rigorous manufacturing and immuno-affinity purification protocols.

    Future Outlook: Expanding Fluorescence-Based Immunodetection

    The Cy5 Goat Anti-Mouse IgG (H+L) Antibody, as a high sensitivity fluorescent secondary antibody, is poised to drive the next generation of immunoassay innovation. Its compatibility with advanced imaging platforms, digital pathology, and multiplexed flow cytometry makes it an ideal partner for systems biology, translational vaccine development, and biomarker discovery.

    Emerging applications include spatial proteomics, high-throughput screening of vaccine candidates, and integration with tissue-clearing and 3D imaging protocols. As demonstrated in the ferritin-based hybrid vaccine study (Song et al., 2026), the ability to sensitively detect and quantify mouse immunoglobulins in complex biological samples will remain central to preclinical research and therapeutic development.

    Researchers seeking reliable, flexible, and high-performance solutions for fluorescence-based immunodetection can confidently rely on APExBIO's Cy5 Goat Anti-Mouse IgG (H+L) Antibody. Its proven record in signal amplification, reproducibility, and workflow adaptability makes it a cornerstone for mouse primary antibody detection in both established and emerging assay formats.

    References:
    [1] Fluorescent Secondary Antibody for Mouse IgG Detection (validation data).
    [2] Advancing Signal Amplification (quantitative sensitivity).
    Song X. et al., 2026. Ferritin-based hybrid protein particle vaccine combining M2e antigen of influenza A virus and S-protein tandem epitopes of SARS-CoV-2. Int J Biol Macromol 339:149867.